Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Ultragenyx Pharmaceutical Inc., 3 years.
Ultragenyx Pharmaceutical Inc.
Director
10x Genomics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −292 | $78.20 | $22,833 |
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −614 | $79.51 | $48,820 |
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −1,325 | $80.82 | $107,082 |
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −2,270 | $81.67 | $185,391 |
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −1,222 | $82.28 | $100,542 |
| Aug 24, 2026 | 10x Genomics Inc. | Open-market sale | −561 | $62.73 | $35,189 |
| Aug 24, 2026 | 10x Genomics Inc. | Open-market sale | −1,646 | $63.97 | $105,289 |
| Jun 16, 2026 | 10x Genomics Inc. | Open-market sale | −5,359 | $32.59 | $174,650 |
| Jun 16, 2026 | 10x Genomics Inc. | Open-market sale | −364 | $33.27 | $12,110 |
| Jun 4, 2026 | 10x Genomics Inc. | Grant or award | +8,829 | — | — |
| May 18, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −5,740 | $25.12 | $144,189 |
| May 14, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +7,751 | — | — |
| Jun 3, 2025 | 10x Genomics Inc. | Grant or award | +15,357 | — | — |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +5,740 | — | — |
| Jun 18, 2024 | Ultragenyx Pharmaceutical Inc. | Grant or award | +5,345 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.